Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08

Stock Information for Rafael Holdings Inc. Class B


Please wait while we load your information from QuoteMedia.